文献速递瓣膜病与结构性心脏病

美国经导管主动脉瓣置换中心的地理可及性:来自STS/ACC TVT登记的研究

Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
PubMed 文献 · JAMA Cardiol · 2020-01-01

该观察性研究利用美国人口普查数据、Google Maps和STS/ACC TVT登记,分析2015年6月至2017年6月美国65岁以上人群及成功经股动脉TAVR患者至TAVR中心的地理可及性。结果显示多数65岁以上人群居住的医院转诊区域内有TAVR中心,患者至植入中心的中位驾车时间为35.0分钟。

要点

  • 美国76.7%的医院转诊区域包含TAVR中心,92.1%的65岁以上人群居住于此类区域。
  • 成功经股动脉TAVR患者至植入中心的中位驾车时间为35.0分钟(IQR 20.0-70.0分钟)。
  • 仅4.3%的患者在家庭邮编所在区域内接受TAVR,所有患者均在所属医院转诊区域内手术。

核心结论

  • 大多数美国65岁以上个体居住的医院转诊区域内有TAVR中心,TAVR服务渗透性较高。
  • 成功经股动脉TAVR患者至植入中心的中位驾车时间为35.0分钟。

研究设计与样本

  • 观察性研究,时间范围为2015年6月1日至2017年6月30日。
  • 分析美国47 527 537名65岁以上个体及31 098名成功经股动脉TAVR并链接到按服务收费Medicare且有可测量驾车时间的患者。

主要发现

  • 40 537个邮编中490个(1.2%)包含TAVR中心,305个医院转诊区域中234个(76.7%)包含TAVR中心。
  • 1 232 568名(2.6%)65岁以上个体居住在含TAVR中心的邮编区域,43 789 169名(92.1%)居住在含TAVR中心的医院转诊区域。
  • 31 098名患者平均(SD)年龄82.4(6.9)岁,14 697名(47.3%)为女性,7422名(23.87%)居住在农村地区。
  • 所有患者(100.0%)在所属医院转诊区域内的TAVR中心接受手术,1350名(4.3%)在家庭邮编所在中心接受TAVR。
  • 至植入TAVR中心的中位驾车时间为35.0分钟(IQR 20.0-70.0分钟),范围从2.0分钟到18小时48分钟。

临床怎么用

  • 在评估TAVR适应证时,可参考患者至TAVR中心的中位驾车时间约35分钟这一地理可及性现状。
  • 需注意多数患者在本医院转诊区域内接受TAVR,跨区域就医较少。

局限性

  • 研究为观察性设计,仅纳入成功经股动脉TAVR并链接到按服务收费Medicare且有可测量驾车时间的患者。
  • 需进一步研究评估TAVR中心地理位置对有TAVR指征个体接受手术的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Geographic access to transcatheter aortic replacement (TAVR) centers varies in the United States as a result of controlled expansion through minimum volume requirements. OBJECTIVE: To describe the current geographic access to TAVR centers in the United States. DESIGN, SETTING, AND PARTICIPANTS: Observational study from June 1, 2015, to June 30, 2017. United States census data were used to describe access to TAVR center. Google Maps and the Society of Thoracic Surgeons American College of Cardiology Transcatheter Valve Therapy Registry were used to describe characteristics of patients undergoing successful TAVR according to proximity to implanting center. The study analyzed 47 527 537 individuals 65 years and older in the United States and 31 098 patients who underwent successful transfemoral TAVR, were linked to fee-for-service Medicare, and had a measurable driving time. MAIN OUTCOMES AND MEASURES: Median driving distance to a TAVR center. RESULTS: Among 40 537 zip codes in the United States, 490 (1.2%) contained a TAVR center, and among 305 hospital referral regions (HRR), 234 (76.7%) contained a TAVR center. Of the 31 749 patients who underwent successful transfemoral TAVR and were linked to fee-for-service Medicare, 31 098 had a measurable driving time. Mean (SD) age was 82.4 (6.9) years, 14 697 patients (47.3%) were women, and 7422 (23.87%) lived in a rural area. This translated to 1 232 568 of 47 527 537 individuals (2.6%) 65 years and older living in a zip code with a TAVR center and 43 789 169 (92.1%) living in an HRR with a TAVR center. Among 31 749 patients who underwent successful transfemoral TAVR and were linked to fee-for-service Medicare, 31 098 had a measurable driving time. All of these patients (100.0%) underwent their procedure in a TAVR center within their HRR, with 1350 (4.3%) undergoing TAVR in a center within their home zip code. Median driving time to implanting TAVR center was 35.0 minutes (IQR, 20.0-70.0 minutes), ranging from 2.0 minutes to 18 hours and 48 minutes. CONCLUSIONS AND RELEVANCE: Most US individuals 65 years and older live in an HRR with a TAVR center. Among patients undergoing successful transfemoral TAVR, median driving time to implanting center was 35.0 minutes. Within the context of the US health care system, where certain advanced procedures and specialized care are centralized, TAVR services have significant penetration. More studies are required to evaluate the effect of geographic location of TAVR sites on access to TAVR procedures among individuals with an indication for a TAVR within the US population.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Marquis-Gravel G, Stebbins A, Kosinski AS, et al. Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. JAMA Cardiol. 2020. PMID: 32936271. doi:10.1001/jamacardio.2020.1725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。